HOVR Prices $25M Offering, Deepening Dilution Risk for Pre-Revenue eVTOL Developer

What happened

New Horizon Aircraft priced a $25 million common share offering led by its largest U.S. institutional holders, issuing ~10 million shares at a discount. The DeepValue report already flagged HOVR as a 'Potential Sell' given its pre-revenue status, going-concern doubts, and reliance on equity financing. This offering confirms the ongoing dilution pattern, with the company having already sold 6.9 million shares via ATM in the prior nine months. The fresh capital extends runway but at the cost of per-share value, as the next major catalyst—full-scale demonstrator flight testing—is not expected until 2027. With a market cap of ~$103 million and minimal asset backing, the stock remains a high-risk bet on execution and further financing.

Implication

For current holders, the $25M offering increases share count by ~22%, pressuring per-share value absent a proportional milestone. The news reinforces that equity issuance is the operating model, not a one-off. Investors should monitor ATM usage and cash burn: if quarterly burn stays above CAD $6M, further dilution is likely before flight-test proof. The bull case depends on the company reducing burn and delivering a firm 2027 flight-test date, which could improve financing terms. Until then, the base case suggests the stock trades down toward the $1.60–$2.60 range as the market prices in ongoing dilution and schedule uncertainty. Avoiding new positions and trimming on any strength above $3.40 remains prudent.

Thesis delta

This offering shifts the thesis from 'potential de-risking' to 'confirmed dilution overhang.' The report's base case already assumed equity issuance, but the size and pricing of this deal—at a likely discount to market—indicates weaker bargaining power than anticipated. The 'Potential Sell' rating is now more justified, with near-term upside capped by dilution and the 2027 flight-test target still distant.